Latest filing published 17 Mar 2021 for Prometheus Biosciences, Inc., €12.7M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Point72 Biotech Private Investments, LLC: trading record in brief
This profile gathers the share dealings of Point72 Biotech Private Investments, LLC in Prometheus Biosciences, Inc. Altogether 3 filings, all relating to 16 March 2021.
The open-market record is one-sided, with 1 purchase worth €12.7M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 17 March 2021, reports an open-market purchase of €12.7M in Prometheus Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Point72 Biotech Private Investments, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲
Same trade as the filing by RTW Investments, LP, counted once
15M USD28SEC800,000 shares@ US$19.00100.0% of flowCommon StockSEC:0001209191-21-021571:2Canonical exit: 14 Jun 2021 (T+90) - 763,327 sharesCommon StockSEC:0001209191-21-021571:0
- 1,084,697 sharesCommon StockSEC:0001209191-21-021571:1
3 of 2 declarations
